Compare BOLT & ATON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOLT | ATON |
|---|---|---|
| Founded | 2015 | 1973 |
| Country | United States | British Virgin Islands |
| Employees | N/A | 4 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 9.3M |
| IPO Year | 2021 | N/A |
| Metric | BOLT | ATON |
|---|---|---|
| Price | $4.56 | $0.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $34.00 | $2.00 |
| AVG Volume (30 Days) | 23.0K | ★ 6.1M |
| Earning Date | 05-13-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,695,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $133.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $3.91 | $0.28 |
| 52 Week High | $7.35 | $13.80 |
| Indicator | BOLT | ATON |
|---|---|---|
| Relative Strength Index (RSI) | 44.32 | 44.61 |
| Support Level | $4.32 | $0.28 |
| Resistance Level | $5.22 | $0.35 |
| Average True Range (ATR) | 0.37 | 0.03 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 24.13 | 71.54 |
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.